86 related articles for article (PubMed ID: 8508400)
1. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma.
Oka K; Nakano T; Arai T
Cancer; 1993 Jul; 72(1):160-4. PubMed ID: 8508400
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone.
Ebara T; Mitsuhashi N; Saito Y; Sakurai H; Hasegawa M; Takahashi M; Takahashi T; Hayakawa K; Niibe H
Gynecol Oncol; 1996 Nov; 63(2):216-8. PubMed ID: 8910630
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone.
Oka K; Hoshi T; Arai T
Cancer; 1992 Sep; 70(6):1545-50. PubMed ID: 1355399
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Jun; 88(12):2766-73. PubMed ID: 10870059
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
Oka K; Nakano T; Arai T
Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
7. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
Oka K; Nakano T; Arai T
Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer Detect Prev; 1998; 22(2):120-8. PubMed ID: 9544432
[TBL] [Abstract][Full Text] [Related]
12. MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy.
Oka K; Arai T
Int J Gynecol Pathol; 1996 Jan; 15(1):23-7. PubMed ID: 8852442
[TBL] [Abstract][Full Text] [Related]
13. Studies on tumor proliferation using monoclonal antibody, Ki 67 and expression of p53 in cancer of the uterine cervix.
Bar JK; Harlozinska A; Markowska J; Nowak M
Eur J Gynaecol Oncol; 1996; 17(5):378-80. PubMed ID: 8933835
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix.
van Bommel PF; Kenemans P; Helmerhorst TJ; Gallee MP; Ivanyi D
Cancer; 1994 Oct; 74(8):2314-20. PubMed ID: 7522949
[TBL] [Abstract][Full Text] [Related]
15. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix.
Huang EY; Chanchien CC; Lin H; Wang CC; Wang CJ; Huang CC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):975-82. PubMed ID: 24139517
[TBL] [Abstract][Full Text] [Related]
18. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
19. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus.
Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE
Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972
[TBL] [Abstract][Full Text] [Related]
20. Lymphoepithelioma-like carcinoma of the uterine cervix with c-erbB-2, p53 oncoprotein expression and DNA quantification.
Walsh CB; Kay E; Prendiville W; Turner M; Leader M
Histopathology; 1993 Dec; 23(6):592-3. PubMed ID: 7906245
[No Abstract] [Full Text] [Related]
[Next] [New Search]